YY1 and glioblastoma: Notably, miR-7-5p is a negative regulator of YY1, and the levels of miR-7-5p expression were downregulated in temozolomide-resistant glioblastoma cells; thus, miR-7-5p overexpression reversed temozolomide resistance in vivo [103].